{
  "name": "Tian Zhang, MD, MHS",
  "profilepic": "/images/tian-zhang-md.jpg",
  "body": "Dr. Zhang received her MD from the Harvard-MIT Health Sciences and Technology (HST) program at Harvard Medical School and completed residency in internal medicine and fellowship in hematology/oncology at Duke University. She is currently Associate Professor within the Division of Medical Oncology and Department of Medicine at Duke, specializing in genitourinary (GU) malignancies. She actively leads both clinical and translational research studies in the GU oncology, Phase 1, and Center for Cancer Immunotherapy groups. She has received research grants from V Foundation for Cancer Research and Kidney Cancer Association. She is the overall study chair for the phase 3 PDIGREE trial for metastatic renal cell carcinoma in the Alliance cooperative group and also serves as PI for several investigator-initiated trials at Duke. Her research focus is in improving novel therapies and biomarkers for patients with GU malignancies.",
  "link2": "https://twitter.com/TiansterZhang",
  "link_title2": "Twitter",
  "link_title": "Profile",
  "link": "https://scholars.duke.edu/person/tian.zhang2"
}